$68.36
1.4%
Price vs. AI Score (Last 150 days)
Data gathered: December 1
Data gathered: December 1
Data Bits
| Data Bits | Value / Change | Benchmark |
|---|---|---|
| Job Posts | 392 -0.3% |
|
| Sentiment | 50 0% |
|
| Webpage traffic | 345,000 -65.2% |
|
| Employee Rating | 80 0% |
|
| Google Adspend | $402 -2.9% |
|
| Google Trends | 42 -16% |
|
| Linkedin Employees | 12,794 N/A |
|
| Lobbying Cost | $110,000 0% |
|
| NPS | 25 N/A |
|
| Patents | 1,345 0.6% |
|
| 4chan Mentions | 0% | N/A |
| Facebook Engagement | 17 -10.5% |
|
| Facebook followers | 14,201 -0% |
|
| Stocktwits Mentions | 2 0% |
|
| Stocktwits Subscribers | 4,597 0% |
|
| Twitter Followers | 10,857 0% |
|
| Youtube Subscribers | 2,380 0% |
|
| Instagram Followers | 4,473 0.1% |
|
| News Mentions | 0% |
|
| Reddit Mentions | 0% |
|
| ESG | 70 0% |
|
| Business outlook | 73 0% |
|
In the news
Edwards Lifesciences Corp. stock rises Thursday, outperforms marketNovember 29 - MarketWatch |
|
 |
Edwards Lifesciences Corp. stock outperforms market on strong trading dayNovember 29 - MarketWatch |
 |
Investing in Edwards Lifesciences (NYSE:EW) five years ago would have delivered you a 28% gainNovember 28 - Yahoo |
Wolfe Research Downgrades Edwards Lifesciences (EW)November 28 - Fintel |
|
|
Edwards Lifesciences Corp. stock outperforms competitors despite losses on the dayNovember 28 - MarketWatch |
Boeing upgraded, Shopify downgraded: Wall Street's top analyst callsNovember 27 - Thefly.com |
|
About Edwards Lifesciences
Edwards Lifesciences Corp is a part of the healthcare sector. The company specializes in the treatment of structural heart disease. It manufactures heart valves and repair products used to replace or repair a patient's diseased or defective heart valve.
| Price | $68.36 |
| Target Price | Sign up |
| Market Cap | $40.9B |
| Dividend Yield | 0.0223 |
| Industry | Medical Devices |
Similar companies
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
|---|---|---|---|---|---|
| Q3 '23 | 1.5B | 790M | 1.13B | 385M | 423M |
| Q2 '23 | 1.54B | 812M | 1.19B | 307M | 569M |
| Q1 '23 | 1.47B | 766M | 1.13B | 341M | 477M |
| Q4 '22 | 1.32B | 674M | 1.09B | 398M | 447M |
| Q3 '22 | 1.33B | 631M | 1.07B | 344M | 506M |
Insider Transactions
| BOBO DONALD E JR filed to sell 39,503 shares at $65.7. November 13 '23 |
| Wood Larry L filed to sell 213,794 shares at $65.6. November 13 '23 |
| MUSSALLEM MICHAEL A filed to sell 4,486 shares at $67.2. November 6 '23 |
| Ullem Scott B. filed to sell 19,248 shares at $62.7. October 31 '23 |
| BOBO DONALD E JR filed to sell 39,503 shares at $70.3. October 13 '23 |
Read more about Edwards Lifesciences and their earnings, price prediction, job posts, sentiment, webpage traffic, employee rating, google adspend, google trends, linkedin employees, lobbying cost, nps, patents, 4chan mentions, facebook engagement, facebook followers, stocktwits mentions, stocktwits subscribers, twitter followers, youtube subscribers, instagram followers, news mentions, reddit mentions, esg, business outlook.